PT 141 PT 141BremelanotideFDA [2026] 141tube TikTok CN109306366B pt141 Google Patents
Pay in 4 interest-free payments of $6.24 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
PT-141 (Bremelanotide) Research & Scientific Overview Jump to: Structure | Mechanism | Studies | Pharmacokinetics | Protocols | Limitations | Lead Researcher | References PT-141 (Bremelanotide) Molecular Structure & Chemical Properties PT-141 represents a significant milestone in sexual dysfunction research as the first FDA-approved melanocortin receptor agonist for hypoactive sexual desire disorder
Peptides.org makes no claims that any products referenced can cure, treat or prevent any conditions, including any conditions referenced on its website or in print materials
It leverages the bodys central pathways (melanocortin and dopamine systems) to produce an erection and heighten libido, rather than directly affecting the penis blood vessels
PT-141 administration has been associated with dopaminergic activity in reward-processing regions in animal models
US$ 28.60
US$ 29.18
US$ 21.80
US$ 20.24
US$ 26.21